- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05423561
Corticalisation After Femoral Nail Dynamization in Hypertrophic Non-unions
June 14, 2022 updated by: Ali Çağrı Tekin, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Sclerotic Bone Formation (Corticalisation) on the Intramedullar Nail Tip in Hypertrophic Non-union Developing After Femoral Transverse Diaphyseal Fractures
In 12 patients with corticalization and hypertrophic pseudarthrosis were present after dynamization, the old nail was removed and nail exchange was performed with a longer and larger diameter nail to pass the region formed in the cortex approximately 2-3cm inferior from the old nail.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Corticalization is cortex-like sclerosis in the distal of the nail and it may indicate the early sign of dynamization treatment failure in hypertrophic nonunion after femoral transverse diaphyseal fractures.
When corticalization is seen during follow-up after dynamization is performed because of non-union of a femoral transverse fracture, nail exchange should be performed without further delay.
More rigid fixation should be applied with a longer and thicker nail crossing the area of corticalization.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
28 years to 49 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subtrochanteric fractures
- Nonunion with Pain
Exclusion Criteria:
- Infection
- Pathological Fracture (Tumor)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: hypertrophic non-union developing after femoral transverse diaphyseal fractures
|
exchange nailing with larger, thicker nail crossing corticalization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Provide Bone Union
Time Frame: 6 months
|
Achievement of bone union with detecting callus formation on radiography after passing the region of corticalisation with a longer and thicker nail
|
6 months
|
Relieving pain in the nonunion area
Time Frame: 6 weeks
|
Detection of reduction of pain scores in the nonunion area and enabling patients to load on the extremity in the early period postoperatively
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2010
Primary Completion (Actual)
July 31, 2020
Study Completion (Actual)
May 5, 2022
Study Registration Dates
First Submitted
June 9, 2022
First Submitted That Met QC Criteria
June 14, 2022
First Posted (Actual)
June 21, 2022
Study Record Updates
Last Update Posted (Actual)
June 21, 2022
Last Update Submitted That Met QC Criteria
June 14, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-48670771-514.99
- 67 (Desicion number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pseudoarthrosis of Bone
-
Sebastian FindeisenBonalive Biomaterials LtdRecruitingPseudoarthrosis of BoneGermany
-
Central Hospital, Nancy, FranceRecruiting
-
Hospices Civils de LyonCompletedPseudoarthrosis of BoneFrance
-
Istituto Ortopedico RizzoliTerminatedPseudoarthrosis of the ClavicleItaly
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero; Instituto Autónomo Hospital...Enrolling by invitationPseudarthrosis | Non Union Fracture | Pseudoarthrosis of Bone | Nonunion Bone FractureVenezuela
-
A-Spine Asia Co., Ltd.RecruitingTrauma | Scoliosis | Degenerative Disc Disease | Tumor | Stenosis | Kyphosis | Deformity | Pseudoarthrosis of SpineTaiwan
-
Universidad Autonoma de Nuevo LeonCompletedPseudoarthrosisMexico
-
Aesculap AGCompletedTrauma | Degenerative Disc Disease | Spinal Stenosis | Cervical Spondylosis | Spondylolisthesis | Deformity of Spine | Instability; Back | Pseudoarthrosis of SpineGermany
-
Fundacion para la Formacion e Investigacion Sanitarias...Carlos III Health Institute; Hospital Universitario Virgen de la ArrixacaCompleted
-
Medicrea, USA Corp.WithdrawnDegenerative Disc Disease | Spinal Stenosis | Spinal Fusion | Kyphoscoliosis | Scoliosis; Adolescence | Pseudoarthrosis of Spine | Kyphoses, Scheuermann